JEZTIQ 2 mg/0.02 mg, extended-release tablet 28 tablets
Active ingredients: DIÉNOGEST, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet and film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JEZTIQ 2 mg/0,02 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 plaquette PVC polyéthylène PVDC aluminium de 28 comprimés (24 comprimés blancs et 4 comprimés verts)
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66399945CIP73029614CIP133400930296141Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé actif blanc | 0,02 mg · un comprimé | SA |
| DIÉNOGESTcomprimé actif blanc | 2 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.